Clinical Trial Update: Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy of Vagitocin for vulvovaginal atrophy in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Atrophy

Drugs mentioned

• Vagitocin

Snippet

Sponsor: PepTonic Medical AB | Conditions: Vulvovaginal Atrophy | Phase 2 | Status: COMPLETED